Exosome RNA Exosome RNA Research & Industry News
Pandorum secures $18 million to advance programmable extracellular vesicles therapies like Kuragenx, expanding global manufacturing and clinical development in regenerative medicine for ocular and systemic diseases...
Read More »Pandorum Technologies Raises US$18 Million in Series B to Advance Global Access to Programmable Tissue Regenerative Therapies
